for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Merit Medical Systems, Inc.

MMSI.OQ

Latest Trade

31.35USD

Change

1.10(+3.64%)

Volume

364,987

Today's Range

30.00

 - 

31.57

52 Week Range

25.71

 - 

66.28

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
30.25
Open
30.11
Volume
364,987
3M AVG Volume
17.80
Today's High
31.57
Today's Low
30.00
52 Week High
66.28
52 Week Low
25.71
Shares Out (MIL)
55.17
Market Cap (MIL)
1,669.04
Forward P/E
17.03
Dividend (Yield %)
--

Next Event

Q3 2019 Merit Medical Systems Inc Earnings Release

Latest Developments

More

Merit Medical Systems Inc Enters Third Amended And Restated Credit Agreement

Merit Medical Q2 NON-GAAP Earnings Per Share $0.42

Merit Medical Acquires Brightwater Medical, Inc.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

Industry

Medical Equipment & Supplies

Contact Info

1600 W Merit Pkwy

+1.801.2531600

http://www.merit.com/

Executive Leadership

Fred P. Lampropoulos

Chairman of the Board, President, Chief Executive Officer

Raul Parra

Chief Financial Officer, Treasurer

Joseph C. Wright

President - International Division

Ronald A. Frost

Chief Operating Officer

Justin J. Lampropoulos

Executive Vice President - Sales, Marketing and Strategy

Key Stats

2.25 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.6K

2017

0.7K

2018

0.9K

2019(E)

1.0K
EPS (USD)

2016

1.010

2017

1.280

2018

1.690

2019(E)

1.768
Price To Earnings (TTM)
40.20
Price To Sales (TTM)
1.76
Price To Book (MRQ)
1.75
Price To Cash Flow (TTM)
13.48
Total Debt To Equity (MRQ)
42.10
LT Debt To Equity (MRQ)
40.52
Return on Investment (TTM)
3.10
Return on Equity (TTM)
2.78

Latest News

BRIEF-Merit Medical Enters Strategic Alliance And Worldwide Distribution With NinePoint Medical

* MERIT MEDICAL ENTERS STRATEGIC ALLIANCE AND WORLDWIDE DISTRIBUTION WITH NINEPOINT MEDICAL

BRIEF-Merit Medical Systems Q1 Earnings Per Share $0.10

* MERIT MEDICAL REPORTS RECORD REVENUES FOR FIRST QUARTER OF 2018

BRIEF-Merit Medical Q4 GAAP Earnings Per Share $0.13

* MERIT MEDICAL REPORTS RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017; MERIT MEETS RANGE OF 2017 GUIDANCE; GIVES 2018 GUIDANCE

BRIEF-Merit Medical Entered Into Third Amendment To Second Amended & Restated Credit Agreement & Incremental Increase Agreement

* MERIT MEDICAL SYSTEMS - ON DEC 13, MERIT ENTERED INTO THIRD AMENDMENT TO SECOND AMENDED & RESTATED CREDIT AGREEMENT & INCREMENTAL INCREASE AGREEMENT

BRIEF-Merit Medical signs purchase agreement with BD for divestment assets

* Merit Medical signs purchase agreement with BD for divestment assets

BRIEF-Merit Medical reports Q3 loss per share $0.07

* Q3 revenue $179.3 million versus I/B/E/S view $181.3 million

BRIEF-ITL Ltd sells Custom Pack business to Merit Medical Systems

* Announces sale of Australian Custom Pack business unit to Merit Medical Systems, Inc for $14.4 mln

BRIEF-Merit Medical Q2 earnings per share $0.19

* Merit Medical reports record revenue and non-GAAP net income* for second quarter 2017, raises 2017 guidance and gives preliminary 2018-2019 guidance

BRIEF-Merit Medical’s Embosphere Microspheres receive FDA 513(f)(2) (de novo) classification

* Merit medical’s embosphere® microspheres receive fda 513(f)(2) (de novo) classification for prostatic artery embolization indication

BRIEF-Merit Medical reports Q1 earnings per share $0.32

* Reaffirms FY 2017 non-gaap earnings per share view $1.15 to $1.20

BRIEF-Takung Art Co says unit and Merit Crown entered into extension of loan agreement - SEC Filing

* On April 4, Hongkong Takung, Merit Crown entered extension of loan agreement to extend term of US$ loans through Dec 31, 2017 - SEC Filing

BRIEF-Merit Medical Q4 non-gaap EPS $0.31

* Merit medical reports results for fourth quarter and year ended december 31, 2016

BRIEF-Merit Medical acquires products from Argon Medical Devices and Catheter Connections

* Merit Medical acquires products from Argon Medical Devices and Catheter Connections Inc

BRIEF-Merit medical systems inc says receives 510(k) clearance for swiftNINJA steerable microcatheter

* Merit medical systems inc says receives 510(k) clearance for swiftNINJA steerable microcatheter

BRIEF-Merit Medical Systems sees FY2016 revenue $603.5 mln - $613.5 mln

* Fy2016 revenue view $606.4 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Merit Medical Q3 non-GAAP earnings per share $0.26

* Merit medical reports sales up 15.3 percent for the quarter ended September 30, 2016

BRIEF-Merit Medical says received subpoena from U.S. Department of Justice

* Says on Oct 19 ,co received subpoena from U.S. DoJ requesting documents regarding marketing,promotional practices relating to products

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up